Further evidence for fampridine use in treating MS

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1657, 2008-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fampridine SR ups the pace in MS

Inpharma, Vol. 1, Iss. 1588, 2007-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Historical overview of the rationale for the pharmacological use of prolonged-release fampridine in multiple sclerosis

By Fernandez Oscar Berger Thomas Hartung Hans-Peter Putzki Norman

Expert Review of Clinical Pharmacology, Vol. 5, Iss. 6, 2012-11 ,pp. : 649-665

Informa Healthcare

Access to resources Recommend Favorite

Prolonged-release fampridine: a guide to its use in multiple sclerosis in the EU

By Lyseng-Williamson Katherine A.

Drugs & Therapy Perspectives, Vol. 28, Iss. 12, 2012-12 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Further evidence for BP reduction with statins

Inpharma, Vol. 1, Iss. 1465, 2004-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Fampridine: Toxidrome: case report

Reactions Weekly, Vol. 1, Iss. 1424, 2012-01 ,pp. : 27-27

Adis International

Access to resources Recommend Favorite